49 citations
,
November 2016 in “Frontiers in Pharmacology” This study found that over 26% of patients using Tripterygium wilfordii Hook F experienced adverse events, highlighting the need for better strategies to manage these risks.
42 citations
,
June 2021 in “Pharmaceutics” This review summarizes the use of 3D printing technologies for creating microneedles and evaluates their associated benefits, challenges, and regulatory considerations, but does not present new experimental results.
40 citations
,
January 2022 in “Nutrients” This review explores the potential impact of nutrition on immune-mediated inflammatory skin diseases and evaluates whether dietary changes could help in treatment planning, but it presents no new clinical outcomes.
22 citations
,
June 2024 in “Health Science Reports” This review highlights the growing use of 3D printing in healthcare, specifically its impact on plastic surgery and prosthetic devices, and stresses the need for further research to address existing knowledge gaps.
20 citations
,
January 2022 in “REVIEWS ON ADVANCED MATERIALS SCIENCE” This review explores how nanoparticles enhance cosmeceutical formulations, analyzing their roles in transporting active ingredients, and highlights the progress and challenges in using nanotechnology for beauty and health products.
18 citations
,
September 2024 in “Journal of the European Academy of Dermatology and Venereology” This review found that the DLQI is widely used as a benchmark in the development and validation of dermatology quality-of-life measures.
18 citations
,
May 2023 in “Preprints.org” This review provides an overview of caffeine's effects on cancer, cardiovascular, immunological, inflammatory, and neurological diseases, highlighting both its potential benefits, such as neuroprotection and anti-aging, and possible adverse effects like elevated blood pressure, anemia, and migraine.
12 citations
,
September 2024 in “MedComm” This review reports on the principles, applications, and future potential of bioprinting technology in fields like tissue engineering and organ regeneration, highlighting recent advancements and identifying ongoing challenges and future directions that require collaborative efforts to fully realize the technology's capabilities.
12 citations
,
September 2024 in “Journal of the European Academy of Dermatology and Venereology” This review identified several changeable psychosocial factors, like acceptance, as potential targets for interventions aimed at reducing self-stigma and improving mental health in affected individuals.
3 citations
,
September 2024 in “Skin Research and Technology” This study outlines current research trends and key focuses in the field of AN, offering insights and potential future research directions for scholars interested in AN scientific research.
2 citations
,
November 2025 in “Pharmacology Research & Perspectives” This study analyzed post-marketing data from the U.S. FDA Adverse Event Reporting System and identified both known and new safety concerns for Avacopan, an anti-neutrophil cytoplasmic antibodies-associated vasculitis treatment, emphasizing the need for monitoring during early treatment stages.
2 citations
,
July 2025 in “BMC Women s Health” This study confirms that many iron deficiency symptoms occur in non-anemic women, with transferrin saturation showing a strong correlation with symptom diversity, suggesting its potential as an early diagnostic biomarker.
2 citations
,
February 2024 in “Journal of the European Academy of Dermatology and Venereology” This study resulted in a draft version of the Patient‐Reported Impact of Dermatological Diseases measure, PRIDD, which includes 27 items refined from patient consensus and is now undergoing psychometric testing.
2 citations
,
February 2023 in “BJUI” This study found that utilizing a clinical pharmacist in perioperative urological services reduced surgical cancellations and resident overtime while improving service efficiency and financial sustainability.
1 citations
,
April 2024 in “JMIR AI” This study highlights potential benefits for public health agencies and policymakers in understanding and communicating about PCC symptomatology and experiences.
June 2026 in “Frontiers in Medicine” This study conducted a large-scale comparison using FAERS data to assess the post-marketing safety profiles of spironolactone, eplerenone, and finerenone, finding unique adverse event patterns for each drug and highlighting the need for personalized safety monitoring and further investigation in other pharmacovigilance databases.
This review explores plant-derived exosomes as promising alternatives to synthetic wound-healing agents due to their ability to regulate signaling pathways involved in skin repair, while also addressing challenges in their clinical application.
March 2026 in “Acta Dermato Venereologica” This study found that dermatology patients with tattoos or piercings may have a higher risk of body dysmorphic disorder tendencies and lower acceptance of their illness.
January 2026 in “AIMS Public Health” This abstract describes the approval of a study by the Japan Registry of Clinical Trials and the North South University Institutional Review Board, but it does not report any results or conclusions.
November 2025 in “BMC Endocrine Disorders” This study found that in PCOS patients, a lower TT/DHT ratio is associated with regular menstruation, while higher ratios are linked to insulin resistance, suggesting its potential as a biomarker for metabolic severity in these patients.
This study reports that subcutaneous testosterone pellets in peri- and postmenopausal women provided sustained hormone release and potential benefits for sexual function, but raised concerns about safety, variability, and dosing inconsistencies.
September 2025 in “Wound Repair and Regeneration” This review suggests that glucagon-like peptide 1 receptor agonists may play a potentially protective role in managing diabetic foot ulcers, particularly by addressing various underlying pathophysiological aspects.
December 2024 in “Archiv Euromedica” This review highlights that diagnosing cicatricial alopecia, a hair loss condition linked to several autoimmune diseases, requires trichoscopy and histopathological examination to differentiate it from similar conditions, with early diagnosis being crucial for effective management.
June 2024 in “Journal of Cosmetic Dermatology” This bibliometric study found a significant increase in research publications on platelet-rich plasma for hair growth from 2006 to 2023, with a shift towards examining clinical efficacy and creating evidence-based guidelines.
October 2023 in “Journal of the European Academy of Dermatology and Venereology” This source outlines the WHO's framework for meaningful engagement of individuals with lived experience of noncommunicable diseases and dermatological conditions, emphasizing eliminating stigma, promoting inclusion, and redistributing power to improve health policies and support systems.
December 2022 in “BMC women's health” In this pilot study, the CNC® device improved body image perceptions in patients with chemotherapy-induced alopecia but did not significantly affect psychological wellbeing; it may help prevent discomfort and enhance everyday life compared to traditional wigs.
October 2022 in “Hair Transplantation” This review discusses common cosmetic problems encountered in hair transplant surgery and reports no new clinical results; it emphasizes the need to consider design and progressive hair loss.
This study identified the Arabidopsis cation chloride cotransporter CCC1 as essential for regulating pH and function in the trans-Golgi network/early endosome, with its absence causing significant growth and stress response defects.
This study found that the Arabidopsis cation chloride cotransporter (CCC1) is crucial for regulating pH and processes in the trans-Golgi-network/early endosome, impacting plant growth and stress responses.
September 2021 in “Physiology News” This abstract only contains a stylized text design and provides no research findings or clinical results.